Baird raised the firm’s price target on Stericycle to $62 from $50 and keeps a Neutral rating on the shares. The firm said while they are encouraged that performance is tracking in line with long-range expectations, they are on the sidelines and would be better buyers on pullbacks given minimal upside to their price target and some lingering risks/uncertainties in the SID business.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SRCL:
- Stericycle, Inc. Reports Results For The Fourth Quarter 2023
- SRCL Earnings this Week: How Will it Perform?
- Stericycle to Present at Raymond James 45th Annual Institutional Investors Conference in March
- Stericycle price target raised to $50 from $45 at Truist
- Stericycle Announces Redemption of 5.375% Senior Notes
